Patent · US Active

Derivatives of psammaplin A, a method for their synthesis and their uses for the prevention or treatment of cancer

US8338473B2 · kind B2 · utility

0Cited by

1References

17Claims

0Family size

Assignees

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR
UNIVERSITE DE STRASBOURG · FR
Institut National de la Sante et de la Recherche Medicale (INSERM) · FR
Universidade de Vito · ES
Seconda Universita Degli Studi di Napoli · IT
Radboud University Nijmegen · NL

Inventors

Hinrich Gronemeyer · Oberkirch, DE
Lucia Altucci · Napoli, IT
Angel De Lera · Vigo, ES
Hendrik Gerard Stunnenberg · Bammental, DE

Key dates

Filing date	Feb 28, 2008
Grant date	Dec 25, 2012
Priority date	—
Expiry date	Nov 29, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Derivatives of psammaplin A responding to formula (I), a method for their synthesis and their use for the preparation of a medicament for preventing and for treating a tumor or a cancer. Formula (I).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.